ESR1 and neoplasm: Endocrine therapy has been used with modest and variable results in the treatment of OC [44], mainly due to tumor heterogeneity, thus it is not surprising that although crucial in OC progression, ERα did not emerge as a “fitness” gene within the investigated cell lines.